首页> 外文期刊>World Journal of Surgical Oncology >Resection of recurrent hepatocellular carcinoma with thrombi in the inferior vena cava, right atrium, and phrenic vein: a report of three cases
【24h】

Resection of recurrent hepatocellular carcinoma with thrombi in the inferior vena cava, right atrium, and phrenic vein: a report of three cases

机译:中腔静脉,右心房和膈静脉的血栓分离复发性肝细胞癌:三种情况下的报告

获取原文
           

摘要

Prognosis for patients with advanced hepatocellular carcinoma with a tumor thrombus in the inferior vena cava or right atrium is extremely poor due to cancer progression, pulmonary embolism, and congestion of the circulatory system caused by right heart failure. Surgical resection of the tumor thrombi may potentially yield better results than non-surgical treatments through prevention of sudden death. However, the benefits of surgical resection in patients with hepatocellular carcinoma and a tumor thrombus extending to the inferior vena cava, right atrium, and potentially in the phrenic vein are unclear. Here, we report three such cases. Of the total 136 patients who underwent hepatectomies for hepatocellular carcinoma in our institution, three patients with prior hepatectomies and recurrent hepatocellular carcinoma had tumor thrombi in the inferior vena cava, right atrium, and phrenic vein. Surgical resections were performed, as there was a possibility of sudden death, despite the risk of leaving residual tumor. For all patients, we performed resection of the tumor thrombi in the inferior vena cava and right atrium and combined diaphragm resection. Surgical resection was performed using the total hepatic vascular exclusion technique in all cases. Additional passive veno-venous bypass was also performed in two cases, in which complete tumor resections could not be achieved. The microscopic surgical margins of the combined resected diaphragms were positive in all cases. Progression-free survival was 20.2, 3.8, and 9.5?months for case 1, 2, and 3, respectively. The respective overall postoperative survival was 98.0, 38.9, and 30.9?months. The patients died due to liver cirrhosis, acute heart failure, and hepatocellular carcinoma, respectively. Sudden death did not occur for any of the patients. Surgical resections may extend prognosis for patients with recurrent hepatocellular carcinoma with tumor thrombi in the inferior vena cava, right atrium, and phrenic vein, although the indications should be considered carefully.
机译:由于癌症进展,肺栓塞和循环系统引起的循环系统造成的肺栓塞,患者晚期肝细胞癌患者的预后患有晚期肝细胞癌,患有肿瘤血栓的患者患者患者肿瘤血管血管血管血管血管血管患者极差。通过预防猝死,肿瘤血栓的手术切除可能比非手术治疗更好的结果。然而,手术切除对肝细胞癌患者的益处和延伸到下腔静脉,右心房和施在膈静脉的肿瘤血栓较小。在这里,我们报告了三种这种情况。在我们机构中肝细胞癌肝细胞癌接受肝切除术的136名患者中,患有先前肝切除术和复发性肝细胞癌的患者在下腔静脉,右心房和膈静脉中具有肿瘤血栓。尽管存在留下残余肿瘤的风险,但表演了手术切除,因为存在猝死的可能性。对于所有患者,我们在下腔静脉和右心房中切除肿瘤血栓,并结合隔膜切除术。在所有情况下使用总肝血管排除技术进行手术切除。额外的被动静脉静脉旁路也在两种情况下进行,其中无法实现完全肿瘤切除。所有病例中联合切除的隔膜的显微镜手术边缘都是阳性的。案例1,2和3的无进展生存率为20.2,3.8和9.5?数月。各个整体术后存活率为98.0,38.9和30.9?个月。患者因肝硬化,急性心力衰竭和肝细胞癌分别死亡。任何患者都没有发生猝死。手术切除术可能对患有肿瘤血栓,右侧腔静脉,右心房和膈静脉进行肿瘤血栓的患者的预后,尽管应仔细考虑适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号